Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License ...
Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License ...
Stay updated with breaking news from Upfront Payment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License ...
In a recent development, the central government has introduced new revisions to the Mineral auction rules. These changes aim to ensure transparency and fair competition in the bidding process. According to the revised rules, the upfront payment for mineral auctions will now be capped at Rs 500 crore.
/PRNewswire/ -- Isomorphic Labs, a digital biology company with a mission to redefine drug discovery using the power of artificial intelligence, today...
DAEJEON, South Korea, December 26, 2023--LegoChem Biosciences Announces License Agreement for LCB84, a Trop2 directed ADC with Janssen Biotech, Inc., a Johnson & Johnson company.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, headquartered in Holon, Israel, to exclusively license its potential first-in-class, pre-clinical antibody ...